Life Cycle Investment Partners Ltd Acquires New Position in Stryker Corporation $SYK

Life Cycle Investment Partners Ltd bought a new stake in shares of Stryker Corporation (NYSE:SYK) in the fourth quarter, Holdings Channel reports. The fund bought 135,364 shares of the medical technology company’s stock, valued at approximately $47,576,000.

A number of other hedge funds have also added to or reduced their stakes in SYK. Brighton Jones LLC grew its holdings in Stryker by 15.4% during the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock valued at $1,643,000 after buying an additional 609 shares in the last quarter. Schnieders Capital Management LLC. purchased a new position in Stryker during the 2nd quarter valued at about $205,000. Marshall Wace LLP grew its holdings in Stryker by 107.9% during the 2nd quarter. Marshall Wace LLP now owns 5,700 shares of the medical technology company’s stock valued at $2,255,000 after buying an additional 77,831 shares in the last quarter. Nebula Research & Development LLC purchased a new position in Stryker during the 2nd quarter valued at about $219,000. Finally, HUB Investment Partners LLC purchased a new position in Stryker during the 2nd quarter valued at about $253,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have weighed in on the company. Truist Financial reaffirmed a “hold” rating and set a $330.00 target price (down from $380.00) on shares of Stryker in a report on Monday, May 4th. William Blair reaffirmed an “outperform” rating on shares of Stryker in a report on Thursday, March 5th. UBS Group cut their price objective on Stryker from $400.00 to $380.00 and set a “neutral” rating for the company in a report on Tuesday, March 17th. Deutsche Bank Aktiengesellschaft set a $315.00 price objective on Stryker in a report on Friday, May 1st. Finally, Wells Fargo & Company cut their price objective on Stryker from $456.00 to $418.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Sixteen research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, Stryker has a consensus rating of “Moderate Buy” and a consensus price target of $395.48.

Insiders Place Their Bets

In related news, VP M Kathryn Fink sold 3,500 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $283.45, for a total value of $992,075.00. Following the completion of the sale, the vice president owned 177 shares in the company, valued at $50,170.65. The trade was a 95.19% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 4.60% of the stock is owned by insiders.

Stryker Stock Performance

NYSE:SYK opened at $316.39 on Friday. The business has a 50 day moving average of $325.22 and a 200 day moving average of $349.82. The company has a market capitalization of $121.29 billion, a price-to-earnings ratio of 36.62, a PEG ratio of 1.99 and a beta of 0.80. Stryker Corporation has a 1-year low of $281.00 and a 1-year high of $404.87. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.11 and a quick ratio of 1.25.

Stryker (NYSE:SYK) last released its earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The firm had revenue of $6.02 billion during the quarter, compared to the consensus estimate of $6.34 billion. Stryker had a return on equity of 23.42% and a net margin of 13.20%.The business’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.84 EPS. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, sell-side analysts predict that Stryker Corporation will post 14.98 earnings per share for the current fiscal year.

Stryker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be given a $0.88 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. Stryker’s payout ratio is presently 40.74%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.